Bivalirudin Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-562

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 63323-562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bival-struc-01.jpg (Bival Struc 01)

Chemical structure of Bivalirudin, showing the peptide sequence with detailed atomic bonds, including side chains and functional groups. The structure includes notation for variable composition (x) in a specific group.*

FDA Label Image

Premi-logo-01.jpg (Premi Logo 01)

FDA Label Image

Bival-label-01.jpg (Bival Label 01)

Label for Bivalirudin for Injection 250 mg per vial, lyophilized powder for solution, by Fresenius Kabi USA, LLC. The label states it is for intravenous use only, single-dose, and unused portions should be discarded. Storage instructions indicate holding at 20° to 25°C. The label includes product identification numbers and a barcode.*

FDA Label Image

Bival-label-02.jpg (Bival Label 02)

Label for Bivalirudin for Injection, 250 mg per vial, lyophilized powder for intravenous use. The label states that each vial contains 250 mg bivalirudin equivalent to about 270 mg bivalirudin trifluoroacetate with 125 mg Mannitol and Sodium Hydroxide for pH adjustment. Comes in a package of 10 single-dose vials. Manufactured by Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.